Parsing multiomics landscape of activated synovial fibroblasts highlights drug targets linked to genetic risk of rheumatoid arthritis
H. Tsuchiya, M. Ota, S. Sumitomo, K. Ishigaki, A. Suzuki, T. Sakata, Y. Tsuchida, H. Inui, J. Hirose, Y. Kochi, Y. Kadono, K. Shirahige, S. Tanaka, K. Yamamoto, K. Fujio
This study analyzes multi-omics data from activated synovial fibroblasts to identify genetic risk factors and potential drug targets for rheumatoid arthritis.
bioRxiv · Jun 3, 2020Immunology